Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-004038
Filing Date
2017-08-17
Accepted
2017-08-17 10:28:55
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q stlt_10q.htm 10-Q 275979
2 CERTIFICATION stlt_ex311.htm EX-31.1 8963
3 CERTIFICATION stlt_ex312.htm EX-31.2 9038
4 CERTIFICATION stlt_ex321.htm EX-32.1 5293
  Complete submission text file 0001477932-17-004038.txt   2573937

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT stlt-20170630.xml EX-101.INS 356631
6 XBRL TAXONOMY EXTENSION SCHEMA stlt-20170630.xsd EX-101.SCH 46563
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stlt-20170630_cal.xml EX-101.CAL 48189
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stlt-20170630_def.xml EX-101.DEF 152858
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stlt-20170630_lab.xml EX-101.LAB 245181
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stlt-20170630_pre.xml EX-101.PRE 222670
Mailing Address 11147 AURORA AVENUE AURORA BUSINESS PARK, BUILDING 3 URBANDALE IA 50322
Business Address 11147 AURORA AVENUE AURORA BUSINESS PARK, BUILDING 3 URBANDALE IA 50322 515-274-9087
Spotlight Innovation Inc. (Filer) CIK: 0001388486 (see all company filings)

EIN.: 980518266 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52542 | Film No.: 171037888
SIC: 2834 Pharmaceutical Preparations